Cancer Biological Therapy Market Size By Product (Monoclonal Antibodies {Naked Monoclonal Antibodies, Conjugated Monoclonal Antibodies, Bispecific Monoclonal Antibodies}, Vaccines {Preventive Vaccines, Therapeutic Vaccines}, Cancer Growth Blockers {Tyrosine Kinase Inhibitors, Proteasome Inhibitors, mTOR Inhibitors}, Blood Cell Growth Factors {Lenograstim, Filgrastim}, Cytokine {Interferon, Interleukin}), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2018 – 2024

Published Date: Dec 2018  |  Report ID: GMI676  |  Authors: Sumant Ugalmugle

Report Format: PDF   |   Pages: 200   |   Base Year: 2017




Summary Table of Contents Industry Coverage Methodology

Report Content

Chapter 1. Methodology

1.1. Methodology

1.2. Market definitions

1.3. Forecast parameters

1.4. Data sources

1.4.1.  Secondary

1.4.1.1. Paid sources

1.4.1.2. Unpaid sources

1.4.2.  Primary

Chapter 2. Executive Summary

2.1. Cancer biological therapy industry 3600 synopsis, 2013 - 2024

2.1.1.  Business trends

2.1.2.  Product trends

2.1.3.  Regional trends

Chapter 3. Cancer Biological Therapy Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2013 - 2024

3.3. Industry impact forces

3.3.1.  Growth drivers

3.3.1.1.    Increasing incidence of cancer worldwide

3.3.1.2.    Growing geriatric population

3.3.1.3.    Technological advancement in cancer biologics in developed countries

3.3.1.4.    Increasing R&D funding coupled with favorable government policies

3.3.2.  Industry pitfalls and challenges

3.3.2.1.    High cost of treatment

3.3.2.2.    Adverse effects of anti-cancer drug therapy

3.4. Growth potential analysis

3.4.1.  By product

3.5. Porter’s analysis

3.6. Competitive landscape, 2017

3.6.1.  Strategy dashboard

3.7. PESTEL analysis

Chapter 4. Cancer Biological Therapy Market, By Product

4.1. Key segment trends

4.2. Monoclonal antibodies (MAB)

4.2.1.  Market size, by region, 2013 – 2024

4.2.2.  Naked MAB

4.2.2.1.    Market size, by region, 2013 – 2024

4.2.3.  Conjugated MAB

4.2.3.1.    Market size, by region, 2013 – 2024

4.2.4.  Bispecific MAB

4.2.4.1.    Market size, by region, 2013 – 2024

4.3. Vaccines

4.3.1.  Market size, by region, 2013 – 2024

4.3.2.  Preventive vaccines

4.3.2.1.    Market size, by region, 2013 – 2024

4.3.3.  Therapeutic vaccines

4.3.3.1.    Market size, by region, 2013 – 2024

4.4. Cancer growth blockers

4.4.1.  Market size, by region, 2013 – 2024

4.4.2.  Tyrosine kinase Inhibitors (TKI)

4.4.2.1.    Market size, by region, 2013 – 2024

4.4.3.  Proteasome Inhibitors (PI)

4.4.3.1.    Market size, by region, 2013 – 2024

4.4.4.  mTOR Inhibitors

4.4.4.1.    Market size, by region, 2013 – 2024

4.5. Blood cell growth factors (BCGF)

4.5.1.  Market size, by region, 2013 – 2024

4.5.2.  Lenograstim

4.5.2.1.    Market size, by region, 2013 – 2024

4.5.3.  Filgrastim

4.5.3.1.    Market size, by region, 2013 – 2024

4.6. Cytokines

4.6.1.  Market size, by region, 2013 – 2024

4.6.2.  Interferons

4.6.2.1.    Market size, by region, 2013 – 2024

4.6.3.  Interleukins

4.6.3.1.    Market size, by region, 2013 – 2024

Chapter 5. Cancer Biological Therapy Market, By Region

5.1. Key regional trends

5.2. North America

5.2.1.  Market size, by country 2013 – 2024

5.2.2.  Market size, by product, 2013 – 2024

5.2.2.1.    Market size, by MAB, 2013 – 2024

5.2.2.2.    Market size, by vaccines, 2013 – 2024

5.2.2.3.    Market size, by cancer growth blockers, 2013 – 2024

5.2.2.4.    Market size, by blood cell growth factors, 2013 – 2024

5.2.2.5.    Market size, by cytokines, 2013 – 2024

5.2.3.  U.S.

5.2.3.1.    Market size, by product, 2013 – 2024

5.2.3.1.1.   Market size, by MAB, 2013 – 2024

5.2.3.1.2.   Market size, by vaccines, 2013 – 2024

5.2.3.1.3.   Market size, by cancer growth blockers, 2013 – 2024

5.2.3.1.4.   Market size, by blood cell growth factors, 2013 – 2024

5.2.3.1.5.   Market size, by cytokines, 2013 – 2024

5.2.4.  Canada

5.2.4.1.    Market size, by product, 2013 – 2024

5.2.4.1.1.   Market size, by MAB, 2013 – 2024

5.2.4.1.2.   Market size, by vaccines, 2013 – 2024

5.2.4.1.3.   Market size, by cancer growth blockers, 2013 – 2024

5.2.4.1.4.   Market size, by blood cell growth factors, 2013 – 2024

5.2.4.1.5.   Market size, by cytokines, 2013 – 2024

5.3. Europe

5.3.1.  Market size, by country 2013 – 2024

5.3.2.  Market size, by product, 2013 – 2024

5.3.2.1.    Market size, by MAB, 2013 – 2024

5.3.2.2.    Market size, by vaccines, 2013 – 2024

5.3.2.3.    Market size, by cancer growth blockers, 2013 – 2024

5.3.2.4.    Market size, by blood cell growth factors, 2013 – 2024

5.3.2.5.    Market size, by cytokines, 2013 – 2024

5.3.3.  Germany

5.3.3.1.    Market size, by product, 2013 – 2024

5.3.3.1.1.   Market size, by MAB, 2013 – 2024

5.3.3.1.2.   Market size, by vaccines, 2013 – 2024

5.3.3.1.3.   Market size, by cancer growth blockers, 2013 – 2024

5.3.3.1.4.   Market size, by blood cell growth factors, 2013 – 2024

5.3.3.1.5.   Market size, by cytokines, 2013 – 2024

5.3.4.  UK

5.3.4.1.    Market size, by product, 2013 – 2024

5.3.4.1.1.   Market size, by MAB, 2013 – 2024

5.3.4.1.2.   Market size, by vaccines, 2013 – 2024

5.3.4.1.3.   Market size, by cancer growth blockers, 2013 – 2024

5.3.4.1.4.   Market size, by blood cell growth factors, 2013 – 2024

5.3.4.1.5.   Market size, by cytokines, 2013 – 2024

5.3.5.  France

5.3.5.1.    Market size, by product, 2013 – 2024

5.3.5.1.1.   Market size, by MAB, 2013 – 2024

5.3.5.1.2.   Market size, by vaccines, 2013 – 2024

5.3.5.1.3.   Market size, by cancer growth blockers, 2013 – 2024

5.3.5.1.4.   Market size, by blood cell growth factors, 2013 – 2024

5.3.5.1.5.   Market size, by cytokines, 2013 – 2024

5.3.6.  Spain

5.3.6.1.    Market size, by product, 2013 – 2024

5.3.6.1.1.   Market size, by MAB, 2013 – 2024

5.3.6.1.2.   Market size, by vaccines, 2013 – 2024

5.3.6.1.3.   Market size, by cancer growth blockers, 2013 – 2024

5.3.6.1.4.   Market size, by blood cell growth factors, 2013 – 2024

5.3.6.1.5.   Market size, by cytokines, 2013 – 2024

5.3.7.  Italy

5.3.7.1.    Market size, by product, 2013 – 2024

5.3.7.1.1.   Market size, by MAB, 2013 – 2024

5.3.7.1.2.   Market size, by vaccines, 2013 – 2024

5.3.7.1.3.   Market size, by cancer growth blockers, 2013 – 2024

5.3.7.1.4.   Market size, by blood cell growth factors, 2013 – 2024

5.3.7.1.5.   Market size, by cytokines, 2013 – 2024

5.4. Asia Pacific

5.4.1.  Market size, by country 2013 – 2024

5.4.2.  Market size, by product, 2013 – 2024

5.4.2.1.    Market size, by MAB, 2013 – 2024

5.4.2.2.    Market size, by vaccines, 2013 – 2024

5.4.2.3.    Market size, by cancer growth blockers, 2013 – 2024

5.4.2.4.    Market size, by blood cell growth factors, 2013 – 2024

5.4.2.5.    Market size, by cytokines, 2013 – 2024

5.4.3.  India

5.4.3.1.    Market size, by product, 2013 – 2024

5.4.3.1.1.   Market size, by MAB, 2013 – 2024

5.4.3.1.2.   Market size, by vaccines, 2013 – 2024

5.4.3.1.3.   Market size, by cancer growth blockers, 2013 – 2024

5.4.3.1.4.   Market size, by blood cell growth factors, 2013 – 2024

5.4.3.1.5.   Market size, by cytokines, 2013 – 2024

5.4.4.  China

5.4.4.1.    Market size, by product, 2013 – 2024

5.4.4.1.1.   Market size, by MAB, 2013 – 2024

5.4.4.1.2.   Market size, by vaccines, 2013 – 2024

5.4.4.1.3.   Market size, by cancer growth blockers, 2013 – 2024

5.4.4.1.4.   Market size, by blood cell growth factors, 2013 – 2024

5.4.4.1.5.   Market size, by cytokines, 2013 – 2024

5.4.5.  Japan

5.4.5.1.    Market size, by product, 2013 – 2024

5.4.5.1.1.   Market size, by MAB, 2013 – 2024

5.4.5.1.2.   Market size, by vaccines, 2013 – 2024

5.4.5.1.3.   Market size, by cancer growth blockers, 2013 – 2024

5.4.5.1.4.   Market size, by blood cell growth factors, 2013 – 2024

5.4.5.1.5.   Market size, by cytokines, 2013 – 2024

5.5. Latin America

5.5.1.  Market size, by country 2013 – 2024

5.5.2.  Market size, by product, 2013 – 2024

5.5.2.1.    Market size, by MAB, 2013 – 2024

5.5.2.2.    Market size, by vaccines, 2013 – 2024

5.5.2.3.    Market size, by cancer growth blockers, 2013 – 2024

5.5.2.4.    Market size, by blood cell growth factors, 2013 – 2024

5.5.2.5.    Market size, by cytokines, 2013 – 2024

5.5.3.  Brazil

5.5.3.1.    Market size, by product, 2013 – 2024

5.5.3.1.1.   Market size, by MAB, 2013 – 2024

5.5.3.1.2.   Market size, by vaccines, 2013 – 2024

5.5.3.1.3.   Market size, by cancer growth blockers, 2013 – 2024

5.5.3.1.4.   Market size, by blood cell growth factors, 2013 – 2024

5.5.3.1.5.   Market size, by cytokines, 2013 – 2024

5.5.4.  Argentina

5.5.4.1.    Market size, by product, 2013 – 2024

5.5.4.1.1.   Market size, by MAB, 2013 – 2024

5.5.4.1.2.   Market size, by vaccines, 2013 – 2024

5.5.4.1.3.   Market size, by cancer growth blockers, 2013 – 2024

5.5.4.1.4.   Market size, by blood cell growth factors, 2013 – 2024

5.5.4.1.5.   Market size, by cytokines, 2013 – 2024

5.5.5.  Mexico

5.5.5.1.    Market size, by product, 2013 – 2024

5.5.5.1.1.   Market size, by MAB, 2013 – 2024

5.5.5.1.2.   Market size, by vaccines, 2013 – 2024

5.5.5.1.3.   Market size, by cancer growth blockers, 2013 – 2024

5.5.5.1.4.   Market size, by blood cell growth factors, 2013 – 2024

5.5.5.1.5.   Market size, by cytokines, 2013 – 2024

5.6. MEA

5.6.1.  Market size, by country 2013 – 2024

5.6.2.  Market size, by product, 2013 – 2024

5.6.2.1.    Market size, by MAB, 2013 – 2024

5.6.2.2.    Market size, by vaccines, 2013 – 2024

5.6.2.3.    Market size, by cancer growth blockers, 2013 – 2024

5.6.2.4.    Market size, by blood cell growth factors, 2013 – 2024

5.6.2.5.    Market size, by cytokines, 2013 – 2024

5.6.3.  South Africa

5.6.3.1.    Market size, by product, 2013 – 2024

5.6.3.1.1.   Market size, by MAB, 2013 – 2024

5.6.3.1.2.   Market size, by vaccines, 2013 – 2024

5.6.3.1.3.   Market size, by cancer growth blockers, 2013 – 2024

5.6.3.1.4.   Market size, by blood cell growth factors, 2013 – 2024

5.6.3.1.5.   Market size, by cytokines, 2013 – 2024

5.6.4.  Saudi Arabia

5.6.4.1.    Market size, by product, 2013 – 2024

5.6.4.1.1.   Market size, by MAB, 2013 – 2024

5.6.4.1.2.   Market size, by vaccines, 2013 – 2024

5.6.4.1.3.   Market size, by cancer growth blockers, 2013 – 2024

5.6.4.1.4.   Market size, by blood cell growth factors, 2013 – 2024

5.6.4.1.5.   Market size, by cytokines, 2013 – 2024

5.6.5.  UAE

5.6.5.1.    Market size, by product, 2013 – 2024

5.6.5.1.1.   Market size, by MAB, 2013 – 2024

5.6.5.1.2.   Market size, by vaccines, 2013 – 2024

5.6.5.1.3.   Market size, by cancer growth blockers, 2013 – 2024

5.6.5.1.4.   Market size, by blood cell growth factors, 2013 – 2024

5.6.5.1.5.   Market size, by cytokines, 2013 – 2024

Chapter 6. Company Profiles

6.1. AbbVie

6.1.1.   Business overview

6.1.2.   Financial data

6.1.3.   Product landscape

6.1.4.   Strategic outlook

6.1.5.   SWOT analysis

6.2. Amgen

6.2.1.   Business overview

6.2.2.   Financial data

6.2.3.   Product landscape

6.2.4.   Strategic outlook

6.2.5.   SWOT analysis

6.3. Astellas

6.3.1.   Business overview

6.3.2.   Financial data

6.3.3.   Product landscape

6.3.4.   Strategic outlook

6.3.5.   SWOT analysis

6.4. AstraZeneca

6.4.1.   Business overview

6.4.2.   Financial data

6.4.3.   Product landscape

6.4.4.   Strategic outlook

6.4.5.   SWOT analysis

6.5. Bayer

6.5.1.   Business overview

6.5.2.   Financial data

6.5.3.   Product landscape

6.5.4.   Strategic outlook

6.5.5.   SWOT analysis

6.6. Celgene Corporation

6.6.1.   Business overview

6.6.2.   Financial data

6.6.3.   Product landscape

6.6.4.   Strategic outlook

6.6.5.   SWOT analysis

6.7. Eisai

6.7.1.   Business overview

6.7.2.   Financial data

6.7.3.   Product landscape

6.7.4.   Strategic outlook

6.7.5.   SWOT analysis

6.8. ELI Lilly and Company

6.8.1.   Business overview

6.8.2.   Financial data

6.8.3.   Product landscape

6.8.4.   Strategic outlook

6.8.5.   SWOT analysis

6.9. F. Hoffmann-La Roche

6.9.1.   Business overview

6.9.2.   Financial data

6.9.3.   Product landscape

6.9.4.   Strategic outlook

6.9.5.   SWOT analysis

6.10.  GlaxoSmithKline

6.10.1.    Business overview

6.10.2.    Financial data

6.10.3.    Product landscape

6.10.4.    Strategic outlook

6.10.5.    SWOT analysis

6.11.  Incyte

6.11.1.    Business overview

6.11.2.    Financial data

6.11.3.    Product landscape

6.11.4.    Strategic outlook

6.11.5.    SWOT analysis

6.12.  Merck

6.12.1.    Business overview

6.12.2.    Financial data

6.12.3.    Product landscape

6.12.4.    Strategic outlook

6.12.5.    SWOT analysis

6.13.  Novartis

6.13.1.    Business overview

6.13.2.    Financial data

6.13.3.    Product landscape

6.13.4.    Strategic outlook

6.13.5.    SWOT analysis

6.14.  Otsuka

6.14.1.    Business overview

6.14.2.    Financial data

6.14.3.    Product landscape

6.14.4.    Strategic outlook

6.14.5.    SWOT analysis

6.15.  Pfizer

6.15.1.    Business overview

6.15.2.    Financial data

6.15.3.    Product landscape

6.15.4.    Strategic outlook

6.15.5.    SWOT analysis

6.16.  Sanofi

6.16.1.    Business overview

6.16.2.    Financial data

6.16.3.    Product landscape

6.16.4.    Strategic outlook

6.16.5.    SWOT analysis

6.17.  Seattle Genetics

6.17.1.    Business overview

6.17.2.    Financial data

6.17.3.    Product landscape

6.17.4.    Strategic outlook

6.17.5.    SWOT analysis

6.18.  Spectrum Pharmaceuticals

6.18.1.    Business overview

6.18.2.    Financial data

6.18.3.    Product landscape

6.18.4.    Strategic outlook

6.18.5.    SWOT analysis

6.19.  Takeda Pharmaceuticals

6.19.1.    Business overview

6.19.2.    Financial data

6.19.3.    Product landscape

6.19.4.    Strategic outlook

6.19.5.    SWOT analysis

 

Data Tables

TABLE 1    Cancer biological therapy (CBT) industry 360º synopsis, 2013 – 2024

TABLE 2    Cancer biological therapy market, 2013-2017 (USD Million)

TABLE 3    Cancer biological therapy market, 2018-2024 (USD Million)

TABLE 4    Cancer biological therapy market, by product, 2013-2017 (USD Million)

TABLE 5    Cancer biological therapy market, by product, 2018-2024 (USD Million)

TABLE 6    Cancer biological therapy market, by region, 2013-2017 (USD Million)

TABLE 7    Cancer biological therapy market, by region, 2018-2024 (USD Million)

TABLE 8    Industry impact forces

TABLE 9    Monoclonal antibodies market size, by region, 2013-2017 (USD Million)

TABLE 10    Monoclonal antibodies market size, by region, 2018-2024 (USD Million)

TABLE 11    Naked MAB market size, by region, 2013-2017 (USD Million)

TABLE 12    Naked MAB market size, by region, 2018-2024 (USD Million)

TABLE 13    Conjugated MAB market size, by region, 2013-2017 (USD Million)

TABLE 14    Conjugated MAB market size, by region, 2018-2024 (USD Million)

TABLE 15    Bi specific MAB market size, by region, 2013-2017 (USD Million)

TABLE 16    Bi specific MAB market size, by region, 2018-2024 (USD Million)

TABLE 17    Vaccines market size, by region, 2013-2017 (USD Million)

TABLE 18    Vaccines market size, by region, 2018-2024 (USD Million)

TABLE 19    Preventive vaccines market size, by region, 2013-2017 (USD Million)

TABLE 20    Preventive vaccines market size, by region, 2018-2024 (USD Million)

TABLE 21    Therapeutic vaccines market size, by region, 2013-2017 (USD Million)

TABLE 22    Therapeutic vaccines market size, by region, 2018-2024 (USD Million)

TABLE 23    Cancer growth blockers market size, by region, 2013-2017 (USD Million)

TABLE 24    Cancer growth blockers market size, by region, 2018-2024 (USD Million)

TABLE 25    TKI market size, by region, 2013-2017 (USD Million)

TABLE 26    TKI market size, by region, 2018-2024 (USD Million)

TABLE 27    PI market size, by region, 2013-2017 (USD Million)

TABLE 28    PI market size, by region, 2018-2024 (USD Million)

TABLE 29    mTOR Inhibitors market size, by region, 2013-2017 (USD Million)

TABLE 30    mTOR Inhibitors market size, by region, 2018-2024 (USD Million)

TABLE 31    BCGF market size, by region, 2013-2017 (USD Million)

TABLE 32    BCGF market size, by region, 2018-2024 (USD Million)

TABLE 33    Lenograstim market size, by region, 2013-2017 (USD Million)

TABLE 34    Lenograstim market size, by region, 2018-2024 (USD Million)

TABLE 35    Filgrastim market size, by region, 2013-2017 (USD Million)

TABLE 36    Filgrastim market size, by region, 2018-2024 (USD Million)

TABLE 37    Cytokines market size, by region, 2013-2017 (USD Million)

TABLE 38    Cytokines market size, by region, 2018-2024 (USD Million)

TABLE 39    Interferons market size, by region, 2013-2017 (USD Million)

TABLE 40    Interferons market size, by region, 2018-2024 (USD Million)

TABLE 41    Interleukins market size, by region, 2013-2017 (USD Million)

TABLE 42    Interleukins market size, by region, 2018-2024 (USD Million)

TABLE 43    North America cancer biological therapy market size, by country, 2013-2017 (USD Million)

TABLE 44    North America cancer biological therapy market size, by country, 2018-2024 (USD Million)

TABLE 45    North America CBT market size, by product, 2013-2017 (USD Million)

TABLE 46    North America CBT market size, by product, 2018-2024 (USD Million)

TABLE 47    North America CBT market size, by MAB, 2013-2017 (USD Million)

TABLE 48    North America CBT market size, by MAB, 2018-2024 (USD Million)

TABLE 49    North America CBT market size, by vaccines, 2013-2017 (USD Million)

TABLE 50    North America CBT market size, by vaccines, 2018-2024 (USD Million)

TABLE 51    North America CBT market size, by cancer growth blockers, 2013-2017 (USD Million)

TABLE 52    North America CBT market size, by cancer growth blockers, 2018-2024 (USD Million)

TABLE 53    North America CBT market size, by blood cell growth factors, 2013-2017 (USD Million)

TABLE 54    North America CBT market size, by blood cell growth factors, 2018-2024 (USD Million)

TABLE 55    North America CBT market size, by cytokines, 2013-2017 (USD Million)

TABLE 56    North America CBT market size, by cytokines, 2018-2024 (USD Million)

TABLE 57    U.S. cancer biological therapy market size, by product, 2013-2017 (USD Million)

TABLE 58    U.S. cancer biological therapy market size, by product, 2018-2024 (USD Million)

TABLE 59    U.S. CBT market size, by MAB, 2013-2017 (USD Million)

TABLE 60    U.S. CBT market size, by MAB, 2018-2024 (USD Million)

TABLE 61    U.S. CBT market size, by vaccines, 2013-2017 (USD Million)

TABLE 62    U.S. CBT market size, by vaccines, 2018-2024 (USD Million)

TABLE 63    U.S. CBT market size, by cancer growth blockers, 2013-2017 (USD Million)

TABLE 64    U.S. CBT market size, by cancer growth blockers, 2018-2024 (USD Million)

TABLE 65    U.S. CBT market size, by blood cell growth factors, 2013-2017 (USD Million)

TABLE 66    U.S. CBT market size, by blood cell growth factors, 2018-2024 (USD Million)

TABLE 67    U.S. CBT market size, by cytokines, 2013-2017 (USD Million)

TABLE 68    U.S. CBT market size, by cytokines, 2018-2024 (USD Million)

TABLE 69    Canada CBT market size, by product, 2013-2017 (USD Million)

TABLE 70    Canada CBT market size, by product, 2018-2024 (USD Million)

TABLE 71    Canada CBT market size, by MAB, 2013-2017 (USD Million)

TABLE 72    Canada CBT market size, by MAB, 2018-2024 (USD Million)

TABLE 73    Canada CBT market size, by vaccines, 2013-2017 (USD Million)

TABLE 74    Canada CBT market size, by vaccines, 2018-2024 (USD Million)

TABLE 75    Canada CBT market size, by cancer growth blockers, 2013-2017 (USD Million)

TABLE 76    Canada CBT market size, by cancer growth blockers, 2018-2024 (USD Million)

TABLE 77    Canada CBT market size, by blood cell growth factors, 2013-2017 (USD Million)

TABLE 78    Canada CBT market size, by blood cell growth factors, 2018-2024 (USD Million)

TABLE 79    Canada CBT market size, by cytokines, 2013-2017 (USD Million)

TABLE 80    Canada CBT market size, by cytokines, 2018-2024 (USD Million)

TABLE 81    Europe CBT size, by country, 2013-2017 (USD Million)

TABLE 82    Europe CBT size, by country, 2018-2024 (USD Million)

TABLE 83    Europe CBT size, by product, 2013-2017 (USD Million)

TABLE 84    Europe CBT size, by product, 2018-2024 (USD Million)

TABLE 85    Europe CBT market size, by MAB, 2013-2017 (USD Million)

TABLE 86    Europe CBT market size, by MAB, 2018-2024 (USD Million)

TABLE 87    Europe CBT market size, by vaccines, 2013-2017 (USD Million)

TABLE 88    Europe CBT market size, by vaccines, 2018-2024 (USD Million)

TABLE 89    Europe CBT market size, by cancer growth blockers, 2013-2017 (USD Million)

TABLE 90    Europe CBT market size, by cancer growth blockers, 2018-2024 (USD Million)

TABLE 91    Europe CBT market size, by blood cell growth factors, 2013-2017 (USD Million)

TABLE 92    Europe CBT market size, by blood cell growth factors, 2018-2024 (USD Million)

TABLE 93    Europe CBT market size, by cytokines, 2013-2017 (USD Million)

TABLE 94    Europe CBT market size, by cytokines, 2018-2024 (USD Million)

TABLE 95    Germany CBT market size, by product, 2013-2017 (USD Million)

TABLE 96    Germany CBT market size, by product, 2018-2024 (USD Million)

TABLE 97    Germany CBT market size, by MAB, 2013-2017 (USD Million)

TABLE 98    Germany CBT market size, by MAB, 2018-2024 (USD Million)

TABLE 99    Germany CBT market size, by vaccines, 2013-2017 (USD Million)

TABLE 100    Germany CBT market size, by vaccines, 2018-2024 (USD Million)

TABLE 101    Germany CBT market size, by cancer growth blockers, 2013-2017 (USD Million)

TABLE 102    Germany CBT market size, by cancer growth blockers, 2018-2024 (USD Million)

TABLE 103    Germany CBT market size, by blood cell growth factors, 2013-2017 (USD Million)

TABLE 104    Germany CBT market size, by blood cell growth factors, 2018-2024 (USD Million)

TABLE 105    Germany CBT market size, by cytokines, 2013-2017 (USD Million)

TABLE 106    Germany CBT market size, by cytokines, 2018-2024 (USD Million)

TABLE 107    UK CBT market size, by product, 2013-2017 (USD Million)

TABLE 108    UK CBT market size, by product, 2018-2024 (USD Million)

TABLE 109    UK CBT market size, by MAB, 2013-2017 (USD Million)

TABLE 110    UK CBT market size, by MAB, 2018-2024 (USD Million)

TABLE 111    UK CBT market size, by vaccines, 2013-2017 (USD Million)

TABLE 112    UK CBT market size, by vaccines, 2018-2024 (USD Million)

TABLE 113    UK CBT market size, by cancer growth blockers, 2013-2017 (USD Million)

TABLE 114    UK CBT market size, by cancer growth blockers, 2018-2024 (USD Million)

TABLE 115    UK CBT market size, by blood cell growth factors, 2013-2017 (USD Million)

TABLE 116    UK CBT market size, by blood cell growth factors, 2018-2024 (USD Million)

TABLE 117    UK CBT market size, by cytokines, 2013-2017 (USD Million)

TABLE 118    UK CBT market size, by cytokines, 2018-2024 (USD Million)

TABLE 119    France CBT market size, by product, 2013-2017 (USD Million)

TABLE 120    France CBT market size, by product, 2018-2024 (USD Million)

TABLE 121    France CBT market size, by MAB, 2013-2017 (USD Million)

TABLE 122    France CBT market size, by MAB, 2018-2024 (USD Million)

TABLE 123    France CBT market size, by vaccines, 2013-2017 (USD Million)

TABLE 124    France CBT market size, by vaccines, 2018-2024 (USD Million)

TABLE 125    France CBT market size, by cancer growth blockers, 2013-2017 (USD Million)

TABLE 126    France CBT market size, by cancer growth blockers, 2018-2024 (USD Million)

TABLE 127    France CBT market size, by blood cell growth factors, 2013-2017 (USD Million)

TABLE 128    France CBT market size, by blood cell growth factors, 2018-2024 (USD Million)

TABLE 129    France CBT market size, by cytokines, 2013-2017 (USD Million)

TABLE 130    France CBT market size, by cytokines, 2018-2024 (USD Million)

TABLE 131    Spain market CBT size, by product, 2013-2017 (USD Million)

TABLE 132    Spain CBT market size, by product, 2018-2024 (USD Million)

TABLE 133    Spain CBT market size, by MAB, 2013-2017 (USD Million)

TABLE 134    Spain CBT market size, by MAB, 2018-2024 (USD Million)

TABLE 135    Spain CBT market size, by vaccines, 2013-2017 (USD Million)

TABLE 136    Spain CBT market size, by vaccines, 2018-2024 (USD Million)

TABLE 137    Spain CBT market size, by cancer growth blockers, 2013-2017 (USD Million)

TABLE 138    Spain CBT market size, by cancer growth blockers, 2018-2024 (USD Million)

TABLE 139    Spain CBT market size, by blood cell growth factors, 2013-2017 (USD Million)

TABLE 140    Spain CBT market size, by blood cell growth factors, 2018-2024 (USD Million)

TABLE 141    Spain CBT market size, by cytokines, 2013-2017 (USD Million)

TABLE 142    Spain CBT market size, by cytokines, 2018-2024 (USD Million)

TABLE 143    Italy CBT market size, by product, 2013-2017 (USD Million)

TABLE 144    Italy CBT market size, by product, 2018-2024 (USD Million)

TABLE 145    Italy CBT market size, by MAB, 2013-2017 (USD Million)

TABLE 146    Italy CBT market size, by MAB, 2018-2024 (USD Million)

TABLE 147    Italy CBT market size, by vaccines, 2013-2017 (USD Million)

TABLE 148    Italy CBT market size, by vaccines, 2018-2024 (USD Million)

TABLE 149    Italy CBT market size, by cancer growth blockers, 2013-2017 (USD Million)

TABLE 150    Italy CBT market size, by cancer growth blockers, 2018-2024 (USD Million)

TABLE 151    Italy CBT market size, by blood cell growth factors, 2013-2017 (USD Million)

TABLE 152    Italy CBT market size, by blood cell growth factors, 2018-2024 (USD Million)

TABLE 153    Italy CBT market size, by cytokines, 2013-2017 (USD Million)

TABLE 154    Italy CBT market size, by cytokines, 2018-2024 (USD Million)

TABLE 155    Asia Pacific CBT market size, by country, 2013-2017 (USD Million)

TABLE 156    Asia Pacific CBT market size, by country, 2018-2024 (USD Million)

TABLE 157    Asia Pacific CBT market size, by product, 2013-2017 (USD Million)

TABLE 158    Asia Pacific CBT market size, by product, 2018-2024 (USD Million)

TABLE 159    Asia Pacific CBT market size, by MAB, 2013-2017 (USD Million)

TABLE 160    Asia Pacific CBT market size, by MAB, 2018-2024 (USD Million)

TABLE 161    Asia Pacific CBT market size, by vaccines, 2013-2017 (USD Million)

TABLE 162    Asia Pacific CBT market size, by vaccines, 2018-2024 (USD Million)

TABLE 163    Asia Pacific CBT market size, by cancer growth blockers, 2013-2017 (USD Million)

TABLE 164    Asia Pacific CBT market size, by cancer growth blockers, 2018-2024 (USD Million)

TABLE 165    Asia Pacific CBT market size, by blood cell growth factors, 2013-2017 (USD Million)

TABLE 166    Asia Pacific CBT market size, by blood cell growth factors, 2018-2024 (USD Million)

TABLE 167    Asia Pacific CBT market size, by cytokines, 2013-2017 (USD Million)

TABLE 168    Asia Pacific CBT market size, by cytokines, 2018-2024 (USD Million)

TABLE 169    India CBT market size, by product, 2013-2017 (USD Million)

TABLE 170    India CBT market size, by product, 2018-2024 (USD Million)

TABLE 171    India CBT market size, by MAB, 2013-2017 (USD Million)

TABLE 172    India CBT market size, by MAB, 2018-2024 (USD Million)

TABLE 173    India CBT market size, by vaccines, 2013-2017 (USD Million)

TABLE 174    India CBT market size, by vaccines, 2018-2024 (USD Million)

TABLE 175    India CBT market size, by cancer growth blockers, 2013-2017 (USD Million)

TABLE 176    India CBT market size, by cancer growth blockers, 2018-2024 (USD Million)

TABLE 177    India CBT market size, by blood cell growth factors, 2013-2017 (USD Million)

TABLE 178    India CBT market size, by blood cell growth factors, 2018-2024 (USD Million)

TABLE 179    India CBT market size, by cytokines, 2013-2017 (USD Million)

TABLE 180    India CBT market size, by cytokines, 2018-2024 (USD Million)

TABLE 181    China CBT market size, by product, 2013-2017 (USD Million)

TABLE 182    China CBT market size, by product, 2018-2024 (USD Million)

TABLE 183    China CBT market size, by MAB, 2013-2017 (USD Million)

TABLE 184    China CBT market size, by MAB, 2018-2024 (USD Million)

TABLE 185    China CBT market size, by vaccines, 2013-2017 (USD Million)

TABLE 186    China CBT market size, by vaccines, 2018-2024 (USD Million)

TABLE 187    China CBT market size, by cancer growth blockers, 2013-2017 (USD Million)

TABLE 188    China CBT market size, by cancer growth blockers, 2018-2024 (USD Million)

TABLE 189    China CBT market size, by blood cell growth factors, 2013-2017 (USD Million)

TABLE 190    China CBT market size, by blood cell growth factors, 2018-2024 (USD Million)

TABLE 191    China CBT market size, by cytokines, 2013-2017 (USD Million)

TABLE 192    China CBT market size, by cytokines, 2018-2024 (USD Million)

TABLE 193    Japan CBT market size, by product, 2013-2017 (USD Million)

TABLE 194    Japan CBT market size, by product, 2018-2024 (USD Million)

TABLE 195    Japan CBT market size, by MAB, 2013-2017 (USD Million)

TABLE 196    Japan CBT market size, by MAB, 2018-2024 (USD Million)

TABLE 197    Japan CBT market size, by vaccines, 2013-2017 (USD Million)

TABLE 198    Japan CBT market size, by vaccines, 2018-2024 (USD Million)

TABLE 199    Japan CBT market size, by cancer growth blockers, 2013-2017 (USD Million)

TABLE 200    Japan CBT market size, by cancer growth blockers, 2018-2024 (USD Million)

TABLE 201    Japan CBT market size, by blood cell growth factors, 2013-2017 (USD Million)

TABLE 202    Japan CBT market size, by blood cell growth factors, 2018-2024 (USD Million)

TABLE 203    Japan CBT market size, by cytokines, 2013-2017 (USD Million)

TABLE 204    Japan CBT market size, by cytokines, 2018-2024 (USD Million)

TABLE 205    Latin America CBT market size, by country, 2013-2017 (USD Million)

TABLE 206    Latin America CBT market size, by country, 2018-2024 (USD Million)

TABLE 207    Latin America CBT market size, by product, 2013-2017 (USD Million)

TABLE 208    Latin America CBT market size, by product, 2018-2024 (USD Million)

TABLE 209    Latin America CBT market size, by MAB, 2013-2017 (USD Million)

TABLE 210    Latin America CBT market size, by MAB, 2018-2024 (USD Million)

TABLE 211    Latin America CBT market size, by vaccines, 2013-2017 (USD Million)

TABLE 212    Latin America CBT market size, by vaccines, 2018-2024 (USD Million)

TABLE 213    Latin America CBT market size, by cancer growth blockers, 2013-2017 (USD Million)

TABLE 214    Latin America CBT market size, by cancer growth blockers, 2018-2024 (USD Million)

TABLE 215    Latin America CBT market size, by blood cell growth factors, 2013-2017 (USD Million)

TABLE 216    Latin America CBT market size, by blood cell growth factors, 2018-2024 (USD Million)

TABLE 217    Latin America CBT market size, by cytokines, 2013-2017 (USD Million)

TABLE 218    Latin America CBT market size, by cytokines, 2018-2024 (USD Million)

TABLE 219    Brazil CBT market size, by product, 2013-2017 (USD Million)

TABLE 220    Brazil CBT market size, by product, 2018-2024 (USD Million)

TABLE 221    Brazil CBT market size, by MAB, 2013-2017 (USD Million)

TABLE 222    Brazil CBT market size, by MAB, 2018-2024 (USD Million)

TABLE 223    Brazil CBT market size, by vaccines, 2013-2017 (USD Million)

TABLE 224    Brazil CBT market size, by vaccines, 2018-2024 (USD Million)

TABLE 225    Brazil CBT market size, by cancer growth blockers, 2013-2017 (USD Million)

TABLE 226    Brazil CBT market size, by cancer growth blockers, 2018-2024 (USD Million)

TABLE 227    Brazil CBT market size, by blood cell growth factors, 2013-2017 (USD Million)

TABLE 228    Brazil CBT market size, by blood cell growth factors, 2018-2024 (USD Million)

TABLE 229    Brazil CBT market size, by cytokines, 2013-2017 (USD Million)

TABLE 230    Brazil CBT market size, by cytokines, 2018-2024 (USD Million)

TABLE 231    Argentina CBT market size, by product, 2013-2017 (USD Million)

TABLE 232    Argentina CBT market size, by product, 2018-2024 (USD Million)

TABLE 233    Argentina CBT market size, by MAB, 2013-2017 (USD Million)

TABLE 234    Argentina CBT market size, by MAB, 2018-2024 (USD Million)

TABLE 235    Argentina CBT market size, by vaccines, 2013-2017 (USD Million)

TABLE 236    Argentina CBT market size, by vaccines, 2018-2024 (USD Million)

TABLE 237    Argentina CBT market size, by cancer growth blockers, 2013-2017 (USD Million)

TABLE 238    Argentina CBT market size, by cancer growth blockers, 2018-2024 (USD Million)

TABLE 239    Argentina CBT market size, by blood cell growth factors, 2013-2017 (USD Million)

TABLE 240    Argentina CBT market size, by blood cell growth factors, 2018-2024 (USD Million)

TABLE 241    Argentina CBT market size, by cytokines, 2013-2017 (USD Million)

TABLE 242    Argentina CBT market size, by cytokines, 2018-2024 (USD Million)

TABLE 243    Mexico CBT market size, by product, 2013-2017 (USD Million)

TABLE 244    Mexico CBT market size, by product, 2018-2024 (USD Million)

TABLE 245    Mexico CBT market size, by MAB, 2013-2017 (USD Million)

TABLE 246    Mexico CBT market size, by MAB, 2018-2024 (USD Million)

TABLE 247    Mexico CBT market size, by vaccines, 2013-2017 (USD Million)

TABLE 248    Mexico CBT market size, by vaccines, 2018-2024 (USD Million)

TABLE 249    Mexico CBT market size, by cancer growth blockers, 2013-2017 (USD Million)

TABLE 250    Mexico CBT market size, by cancer growth blockers, 2018-2024 (USD Million)

TABLE 251    Mexico CBT market size, by blood cell growth factors, 2013-2017 (USD Million)

TABLE 252    Mexico CBT market size, by blood cell growth factors, 2018-2024 (USD Million)

TABLE 253    Mexico CBT market size, by cytokines, 2013-2017 (USD Million)

TABLE 254    Mexico CBT market size, by cytokines, 2018-2024 (USD Million)

TABLE 255    MEA CBT market size, by country, 2013-2017 (USD Million)

TABLE 256    MEA CBT market size, by country, 2018-2024 (USD Million)

TABLE 257    MEA CBT market size, by product, 2013-2017 (USD Million)

TABLE 258    MEA CBT market size, by product, 2018-2024 (USD Million)

TABLE 259    MEA CBT market size, by MAB, 2013-2017 (USD Million)

TABLE 260    MEA CBT market size, by MAB, 2018-2024 (USD Million)

TABLE 261    MEA CBT market size, by vaccines, 2013-2017 (USD Million)

TABLE 262    MEA CBT market size, by vaccines, 2018-2024 (USD Million)

TABLE 263    MEA CBT market size, by cancer growth blockers, 2013-2017 (USD Million)

TABLE 264    MEA CBT market size, by cancer growth blockers, 2018-2024 (USD Million)

TABLE 265    MEA CBT market size, by blood cell growth factors, 2013-2017 (USD Million)

TABLE 266    MEA CBT market size, by blood cell growth factors, 2018-2024 (USD Million)

TABLE 267    MEA CBT market size, by cytokines, 2013-2017 (USD Million)

TABLE 268    MEA CBT market size, by cytokines, 2018-2024 (USD Million)

TABLE 269    South Africa CBT market size, by product, 2013-2017 (USD Million)

TABLE 270    South Africa CBT market size, by product, 2018-2024 (USD Million)

TABLE 271    South Africa CBT market size, by MAB, 2013-2017 (USD Million)

TABLE 272    South Africa CBT market size, by MAB, 2018-2024 (USD Million)

TABLE 273    South Africa CBT market size, by vaccines, 2013-2017 (USD Million)

TABLE 274    South Africa CBT market size, by vaccines, 2018-2024 (USD Million)

TABLE 275    South Africa CBT market size, by cancer growth blockers, 2013-2017 (USD Million)

TABLE 276    South Africa CBT market size, by cancer growth blockers, 2018-2024 (USD Million)

TABLE 277    South Africa CBT market size, by blood cell growth factors, 2013-2017 (USD Million)

TABLE 278    South Africa CBT market size, by blood cell growth factors, 2018-2024 (USD Million)

TABLE 279    South Africa CBT market size, by cytokines, 2013-2017 (USD Million)

TABLE 280    South Africa CBT market size, by cytokines, 2018-2024 (USD Million)

TABLE 281    Saudi Arabia CBT market size, by product, 2013-2017 (USD Million)

TABLE 282    Saudi Arabia CBT market size, by product, 2018-2024 (USD Million)

TABLE 283    Saudi Arabia CBT market size, by MAB, 2013-2017 (USD Million)

TABLE 284    Saudi Arabia CBT market size, by MAB, 2018-2024 (USD Million)

TABLE 285    Saudi Arabia CBT market size, by vaccines, 2013-2017 (USD Million)

TABLE 286    Saudi Arabia CBT market size, by vaccines, 2018-2024 (USD Million)

TABLE 287    Saudi Arabia CBT market size, by cancer growth blockers, 2013-2017 (USD Million)

TABLE 288    Saudi Arabia CBT market size, by cancer growth blockers, 2018-2024 (USD Million)

TABLE 289    Saudi Arabia CBT market size, by blood cell growth factors, 2013-2017 (USD Million)

TABLE 290    Saudi Arabia CBT market size, by blood cell growth factors, 2018-2024 (USD Million)

TABLE 291    Saudi Arabia CBT market size, by cytokines, 2013-2017 (USD Million)

TABLE 292    Saudi Arabia CBT market size, by cytokines, 2018-2024 (USD Million)

TABLE 293    UAE CBT market size, by product, 2013-2017 (USD Million)

TABLE 294    UAE CBT market size, by product, 2018-2024 (USD Million)

TABLE 295    UAE CBT market size, by MAB, 2013-2017 (USD Million)

TABLE 296    UAE CBT market size, by MAB, 2018-2024 (USD Million)

TABLE 297    UAE CBT market size, by vaccines, 2013-2017 (USD Million)

TABLE 298    UAE CBT market size, by vaccines, 2018-2024 (USD Million)

TABLE 299    UAE CBT market size, by cancer growth blockers, 2013-2017 (USD Million)

TABLE 300    UAE CBT market size, by cancer growth blockers, 2018-2024 (USD Million)

TABLE 301    UAE CBT market size, by blood cell growth factors, 2013-2017 (USD Million)

TABLE 302    UAE CBT market size, by blood cell growth factors, 2018-2024 (USD Million)

TABLE 303    UAE CBT market size, by cytokines, 2013-2017 (USD Million)

TABLE 304    UAE CBT market size, by cytokines, 2018-2024 (USD Million)
 

Charts & Figures

FIG. 1    Industry segmentation

FIG. 2    Global cancer biological therapy market, 2013 - 2024 (USD Million)

FIG. 3    Growth potential analysis, by product

FIG. 4    Porter’s analysis

FIG. 5    Strategy dashboard

FIG. 6    PESTEL Analysis

 

Buy NowImmediate delivery available

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Premium Report Details

  • Published Date: Dec 2018
  • Pages: 200
  • Tables: 304
  • Charts / Figures: 6
  • Companies covered: 19
  • Countries covered: 16

Benefits of Association

Data Coverage & Quality

GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.

Client Trust & Security

GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.

Customer Service

Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.

GMIPulse, our report store

We have introduced ‘GMIPulse’, which is our report store; designed to offer clients a one-stop platform for all market research and business intelligence requirements. Clients can access reports, presentations, raw data excel sheets as well as detailed company profiles. GMIPulse allows you to track relevant industries and stay informed with latest innovation, competitive and regulatory developments to help design strategic framework.

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X